Study on HDHD3: Potential Drug Target and Biomarker (G81932)

Target Name: HDHD3

NCBI ID: G81932

HDHD3

Other Name(s): 2810435D12Rik | haloacid dehalogenase-like hydrolase domain-containing protein 3 | C9orf158 | HDHD3_HUMAN | Haloacid dehalogenase-like hydrolase domain-containing protein 3 | haloacid dehalogenase like hydrolase domain containing 3 | HDHD3 variant 1 | Haloacid dehalogenase like hydrolase domain containing 3, transcript variant 1

Study on HDHD3: Potential Drug Target and Biomarker

HDHD3 (2810435D12Rik) is a drug target and a biomarker that is being studied for its potential role in the treatment of various diseases, including cancer. It is a protein that is expressed in various tissues and cells in the body, including the brain, heart, and blood vessels.

One of the most promising aspects of HDHD3 is its potential as a drug target. Researchers are studying how the protein interacts with other molecules in the body to cause disease. This is important because understanding how a protein functions can help identify potential new treatments.

In addition to its potential as a drug target, HDHD3 is also being studied as a biomarker. This means that researchers are using the protein to diagnose and monitor certain diseases. For example, HDHD3 is being tested as a potential biomarker for cancer, with the goal of using the protein to detect the disease earlier on in its development.

Another promising aspect of HDHD3 is its structure. Researchers have identified a unique shape to the protein that makes it an attractive target for drugs. This structure allows the protein to interact with other molecules in the body, making it more likely to be a good candidate for treatment.

While HDHD3 is still in the early stages of research, it is already showing promise as a potential drug target and biomarker. Future studies will be important in understanding its full potential and determining its safety and effectiveness as a treatment.

In conclusion, HDHD3 is a protein that is being studied for its potential as a drug target and biomarker. Its unique structure and potential interactions with other molecules in the body make it an attractive candidate for treatment. As research continues, it will be important to determine its safety and effectiveness as a treatment for various diseases.

Protein Name: Haloacid Dehalogenase Like Hydrolase Domain Containing 3

The "HDHD3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HDHD3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets